Top Losers

Discovery Communications (NASDAQ: DISCA) fell 3.23% to $41.03 after the company executed a series C stock dividend Wednesday. China Ceramics Co (NASDAQ: CCCL) shares dipped 38.52% to $0.83. China Ceramics regained compliance with Nasdaq listing rules. Nanosphere (NASDAQ: NSPH) dropped 30.99%...

Thoratec (NASDAQ: THOR) fell 26.01% to $24.10 in pre-market trading after the company reported downbeat second-quarter sales and issued a disappointing 2014 earnings outlook.. PhotoMedex (NASDAQ: PHMD) shares declined 5.91% to $10.18 in pre-market trading after the company reported weaker-than-...

Rocket Fuel (NASDAQ: FUEL) shares dipped 27.03% to $18.06 after the company reported a Q2 loss of $0.11 per share on revenue of $92.60 million. Rocket Fuel also announced the acquisition of [x+1] for $230 million. Cytori Therapeutics (NASDAQ: CYTX) shares slipped 24.77% to $1.58 after the company...

Rocket Fuel (NASDAQ: FUEL) fell 24.20% to $18.76 in pre-market trading after the company reported a Q2 loss of $0.11 per share on revenue of $92.60 million. Rocket Fuel also announced the acquisition of [x+1] for $230 million. Sprint (NYSE: S) shares slipped 17.58% to $6.00 in pre-market trading...

Enzymotec (NASDAQ: ENZY) shares tumbled 35.91% to $9.60 after the company reported Q2 earnings of $0.02 per share and issued a weak FY14 earnings forecast. RetailMeNot (NASDAQ: SALE) shares dipped 22.92% to $19.50 after the company reported Q2 earnings of $0.08 per share on revenue of $59.50...

RetailMeNot (NASDAQ: SALE) fell 22.45% to $19.62 in pre-market trading after the company reported Q2 earnings of $0.08 per share on revenue of $59.50 million. RBC Capital downgraded RetailMeNot from Outperform to Sector Perform and lowered the price target from $42.00 to $24.00. Five9 (NASDAQ: FIVN...

Insmed (NASDAQ: INSM) dropped 23.13% to $13.26 after the company reported that it will file a Marketing Authorization Application in Europe for Arikayce by the end of 2014. The company also announced that it will start its Phase 3 study. ITT Educational Services (NYSE: ESI) declined 20.13% to $11....

Insmed (NASDAQ: INSM) shares declined 20.29% to $13.75 in pre-market trading after the company reported that it will file a Marketing Authorization Application in Europe for Arikayce by the end of 2014. The company also announced that it will start its Phase 3 study. Noble (NYSE: NE) fell 11.55% to...

Vocera Communications (NYSE: VCRA) shares dropped 26.09% to $9.29 after the company reported Q2 results and appointed Justin Spencer as Executive Vice President and Chief Financial Officer. ServiceSource International (NASDAQ: SREV) shares declined 26.07% to $3.28 on weaker-than-expected Q2 results...

Web.com Group (NASDAQ: WWWW) fell 20.83% to $21.02 in pre-market trading after the company reported Q2 results and announced the acquisition of Scoot. The company also issued a weak FY14 forecast. Pixelworks (NASDAQ: PXLW) dropped 15.37% to $6.66 in pre-market trading after the company reported a...

EDAP TMS SA (NASDAQ: EDAP) shares slipped 39.77% to $2.06 following the FDA Panel rejection of Ablatherm-HIFU for the treatment of prostate cancer. eHealth (NASDAQ: EHTH) declined 31.03% to $21.83 after the company reported downbeat quarterly revenue and issued a weak FY14 forecast. QuickLogic (...

EDAP TMS SA (NASDAQ: EDAP) fell 39.47% to $2.07 in pre-market trading following the FDA Panel rejection of Ablatherm-HIFU for the treatment of prostate cancer. QuickLogic (NASDAQ: QUIK) dropped 23.40% to $3.24 in pre-market trading after the company reported a Q2 loss of $0.04 per share on revenue...

Alexco Resource (NYSE: AXU) shares slipped 16.81% to $1.04 after the company announced a C$5 Million equity financing. Merit Medical Systems (NASDAQ: MMSI) fell 15.67% to $12.43 after the company reported downbeat quarterly results and issued a weak FY14 forecast. Destination Maternity (NASDAQ:...

Buffalo Wild Wings (NASDAQ: BWLD) fell 9.51% to $151.25 in pre-market trading despite the company beating Q2 expectations and raising its 2014 outlook. Wunderlich Securities analyst Robert M. Derrington lowered the price target on the stock from $180.00 to $170.00. Orexigen Therapeutics (NASDAQ:...

Meridian Interstate Bancorp (NASDAQ: EBSB) shares tumbled 58.73% to $10.49 after the company announced the closing of stock offering and completion of conversion transaction. Galectin Therapeutics (NASDAQ: GALT) dropped 47.87% to $7.58 following the release of 8-K. Form 8-K from Galectin showed...